PartnershipJul 9, 2026, 07:37 AM
Virax Biolabs Partners with Fosun for ImmuneSelect in SE Asia
AI Summary
Virax Biolabs Group Limited announced that its subsidiary, Virax Biolabs (UK) Limited, has entered into an exclusive multi-country commercial supply agreement with Fosun Diagnostics. This agreement covers six Southeast Asian markets for Virax's ImmuneSelect research-use immune profiling product line. The partnership establishes a framework for immediate product supply via purchase orders, supporting near-term revenue opportunities and regional commercial expansion. This is considered a significant commercial milestone, providing access to key markets through a leading regional diagnostics organization.
Key Highlights
- Virax Biolabs (UK) signed an exclusive multi-country commercial supply agreement with Fosun Diagnostics.
- The agreement covers six Southeast Asian markets: Thailand, Vietnam, Indonesia, Philippines, Singapore, and Malaysia.
- It is for Virax's ImmuneSelect research-use immune profiling product line.
- The framework allows for immediate product supply under purchase orders.
- Supports near-term potential revenue opportunities and regional commercial expansion.
- Fosun Diagnostics is a core entity of Fosun Medtech, a division of Fosun Pharma.
- Initial focus is on tuberculosis-related research applications in Thailand.
Price Impact
More from VRAX